Journal of Pathology Informatics最新文献

{"title":"Smartphone-based machine learning model for real-time assessment of medical kidney biopsy","authors":"Odianosen J. Eigbire-Molen ,&nbsp;Clarissa A. Cassol ,&nbsp;Daniel J. Kenan ,&nbsp;Johnathan O.H. Napier ,&nbsp;Lyle J. Burdine ,&nbsp;Shana M. Coley ,&nbsp;Shree G. Sharma","doi":"10.1016/j.jpi.2024.100385","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100385","url":null,"abstract":"<div><h3>Background</h3><p>Kidney biopsy is the gold-standard for diagnosing medical renal diseases, but the accuracy of the diagnosis greatly depends on the quality of the biopsy specimen, particularly the amount of renal cortex obtained. Inadequate biopsies, characterized by insufficient cortex or predominant medulla, can lead to inconclusive or incorrect diagnoses, and repeat biopsy. Unfortunately, there has been a concerning increase in the rate of inadequate kidney biopsies, and not all medical centers have access to trained professionals who can assess biopsy adequacy in real time. In response to this challenge, we aimed to develop a machine learning model capable of assessing the percentage cortex of each biopsy pass using smartphone images of the kidney biopsy tissue at the time of biopsy.</p></div><div><h3>Methods</h3><p>747 kidney biopsy cores and corresponding smartphone macro images were collected from five unused deceased donor kidneys. Each core was imaged, formalin-fixed, sectioned, and stained with Periodic acid–Schiff (PAS) to determine cortex percentage. The fresh unfixed core images were captured using the macro camera on an iPhone 13 Pro. Two experienced renal pathologists independently reviewed the PAS-stained sections to determine the cortex percentage. For the purpose of this study, the biopsies with less than 30% cortex were labeled as inadequate, while those with 30% or more cortex were classified as adequate. The dataset was divided into training (<em>n</em>=643), validation (<em>n</em>=30), and test (<em>n</em>=74) sets. Preprocessing steps involved converting High-Efficiency Image Container iPhone format images to JPEG, normalization, and renal tissue segmentation using a U-Net deep learning model. Subsequently, a classification deep learning model was trained on the renal tissue region of interest and corresponding class label.</p></div><div><h3>Results</h3><p>The deep learning model achieved an accuracy of 85% on the training data. On the independent test dataset, the model exhibited an accuracy of 81%. For inadequate samples in the test dataset, the model showed a sensitivity of 71%, suggesting its capability to identify cases with inadequate cortical representation. The area under the receiver-operating curve (AUC-ROC) on the test dataset was 0.80.</p></div><div><h3>Conclusion</h3><p>We successfully developed and tested a machine learning model for classifying smartphone images of kidney biopsies as either adequate or inadequate, based on the amount of cortex determined by expert renal pathologists. The model's promising results suggest its potential as a smartphone application to assist real-time assessment of kidney biopsy tissue, particularly in settings with limited access to trained personnel. Further refinements and validations are warranted to optimize the model's performance.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100385"},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000245/pdfft?md5=aa0cdf6fbf647b60d197599f7a7fc32d&pid=1-s2.0-S2153353924000245-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Joining forces for pathology diagnostics with AI assistance: The EMPAIA initiative","authors":"Norman Zerbe ,&nbsp;Lars Ole Schwen ,&nbsp;Christian Geißler ,&nbsp;Katja Wiesemann ,&nbsp;Tom Bisson ,&nbsp;Peter Boor ,&nbsp;Rita Carvalho ,&nbsp;Michael Franz ,&nbsp;Christoph Jansen ,&nbsp;Tim-Rasmus Kiehl ,&nbsp;Björn Lindequist ,&nbsp;Nora Charlotte Pohlan ,&nbsp;Sarah Schmell ,&nbsp;Klaus Strohmenger ,&nbsp;Falk Zakrzewski ,&nbsp;Markus Plass ,&nbsp;Michael Takla ,&nbsp;Tobias Küster ,&nbsp;André Homeyer ,&nbsp;Peter Hufnagl","doi":"10.1016/j.jpi.2024.100387","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100387","url":null,"abstract":"<div><p>Over the past decade, artificial intelligence (AI) methods in pathology have advanced substantially. However, integration into routine clinical practice has been slow due to numerous challenges, including technical and regulatory hurdles in translating research results into clinical diagnostic products and the lack of standardized interfaces.</p><p>The open and vendor-neutral EMPAIA initiative addresses these challenges. Here, we provide an overview of EMPAIA's achievements and lessons learned. EMPAIA integrates various stakeholders of the pathology AI ecosystem, i.e., pathologists, computer scientists, and industry. In close collaboration, we developed technical interoperability standards, recommendations for AI testing and product development, and explainability methods. We implemented the modular and open-source EMPAIA Platform and successfully integrated 14 AI-based image analysis apps from eight different vendors, demonstrating how different apps can use a single standardized interface. We prioritized requirements and evaluated the use of AI in real clinical settings with 14 different pathology laboratories in Europe and Asia. In addition to technical developments, we created a forum for all stakeholders to share information and experiences on digital pathology and AI. Commercial, clinical, and academic stakeholders can now adopt EMPAIA's common open-source interfaces, providing a unique opportunity for large-scale standardization and streamlining of processes.</p><p>Further efforts are needed to effectively and broadly establish AI assistance in routine laboratory use. To this end, a sustainable infrastructure, the non-profit association EMPAIA International, has been established to continue standardization and support broad implementation and advocacy for an AI-assisted digital pathology future.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100387"},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000269/pdfft?md5=93cff7c5dd94e55a015f5beb1d21f7eb&pid=1-s2.0-S2153353924000269-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141422757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A novel Slide-seq based image processing software to identify gene expression at the single cell level","authors":"Th.I. Götz ,&nbsp;X. Cong ,&nbsp;S. Rauber ,&nbsp;M. Angeli ,&nbsp;E.W. Lang ,&nbsp;A. Ramming ,&nbsp;C. Schmidkonz","doi":"10.1016/j.jpi.2024.100384","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100384","url":null,"abstract":"<div><p>Analysis of gene expression at the single-cell level could help predict the effectiveness of therapies in the field of chronic inflammatory diseases such as arthritis. Here, we demonstrate an adopted approach for processing images from the Slide-seq method. Using a puck, which consists of about 50,000 DNA barcode beads, an RNA sequence of a cell is to be read. The pucks are repeatedly brought into contact with liquids and then recorded with a conventional epifluorescence microscope. The image analysis initially consists of stitching the partial images of a sequence recording, registering images from different sequences, and finally reading out the bases. The new method enables the use of an inexpensive epifluorescence microscope instead of a confocal microscope.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100384"},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000233/pdfft?md5=4839c565f8920eeea61c5ef01d5bb248&pid=1-s2.0-S2153353924000233-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141444222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eye tracking in digital pathology: A comprehensive literature review","authors":"Alana Lopes ,&nbsp;Aaron D. Ward ,&nbsp;Matthew Cecchini","doi":"10.1016/j.jpi.2024.100383","DOIUrl":"10.1016/j.jpi.2024.100383","url":null,"abstract":"<div><p>Eye tracking has been used for decades in attempt to understand the cognitive processes of individuals. From memory access to problem-solving to decision-making, such insight has the potential to improve workflows and the education of students to become experts in relevant fields. Until recently, the traditional use of microscopes in pathology made eye tracking exceptionally difficult. However, the digital revolution of pathology from conventional microscopes to digital whole slide images allows for new research to be conducted and information to be learned with regards to pathologist visual search patterns and learning experiences. This has the promise to make pathology education more efficient and engaging, ultimately creating stronger and more proficient generations of pathologists to come. The goal of this review on eye tracking in pathology is to characterize and compare the visual search patterns of pathologists. The PubMed and Web of Science databases were searched using ‘pathology’ AND ‘eye tracking’ synonyms. A total of 22 relevant full-text articles published up to and including 2023 were identified and included in this review. Thematic analysis was conducted to organize each study into one or more of the 10 themes identified to characterize the visual search patterns of pathologists: (1) effect of experience, (2) fixations, (3) zooming, (4) panning, (5) saccades, (6) pupil diameter, (7) interpretation time, (8) strategies, (9) machine learning, and (10) education. Expert pathologists were found to have higher diagnostic accuracy, fewer fixations, and shorter interpretation times than pathologists with less experience. Further, literature on eye tracking in pathology indicates that there are several visual strategies for diagnostic interpretation of digital pathology images, but no evidence of a superior strategy exists. The educational implications of eye tracking in pathology have also been explored but the effect of teaching novices how to search as an expert remains unclear. In this article, the main challenges and prospects of eye tracking in pathology are briefly discussed along with their implications to the field.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100383"},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000221/pdfft?md5=01458aa9d7539a3f8a155a98d18ad8ba&pid=1-s2.0-S2153353924000221-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141024415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CDK: A novel high-performance transfer feature technique for early detection of osteoarthritis","authors":"Mohammad Shariful Islam ,&nbsp;Mohammad Abu Tareq Rony","doi":"10.1016/j.jpi.2024.100382","DOIUrl":"10.1016/j.jpi.2024.100382","url":null,"abstract":"<div><p>Knee osteoarthritis (OA) is a prevalent condition causing significant disability, particularly among the elderly, necessitating advancements in diagnostic methodologies to facilitate early detection and treatment. Traditional OA diagnosis, relying on radiography and physical exams, faces limitations in accuracy and objectivity. This underscores the need for more advanced diagnostic methods, such as machine learning (ML) and deep learning (DL), to improve OA detection and classification. This research introduces a novel ensemble learning approach for image data feature extraction which ingeniously combines the strengths of 2 advanced (ML) models with a (DL) method to substantially improve the accuracy of OA detection from radiographic images. This innovative strategy aims to address the limitations of traditional diagnostic tools by leveraging the enhanced sensitivity and specificity of combined ML and DL models. The methodology deployed in this study encompasses the application of 10 ML models to a comprehensive publicly available Kaggle dataset with a total of 3615 samples of knee X-ray images. Through rigorous k-fold cross-validation and meticulous hyperparameter optimization, we also included evaluation metrics like accuracy, receiver operating characteristic, precision, recall, and F1-score to assess our models' performance effectively. The proposed novel CDK (convolutional neural network, decision tree, K-nearest classifier) ensemble approach for feature extraction is designed to synergize the predictive capabilities of individual models, thereby significantly improving the detection accuracy of OA indicators within radiographic images. We applied several ML and DL approaches to the newly created feature set to evaluate performance. The CDK ensemble model outperformed state-of-the-art studies with a high-performance score of 99.72% accuracy. This remarkable achievement underscores the model's exceptional capability in the early detection of OA, highlighting its superiority in comparison to existing methods.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100382"},"PeriodicalIF":0.0,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S215335392400021X/pdfft?md5=7758136ea8b6ff5e5d21a4755ae40c6d&pid=1-s2.0-S215335392400021X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141028032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer","authors":"Sushant Patkar ,&nbsp;Stephanie Harmon ,&nbsp;Isabell Sesterhenn ,&nbsp;Rosina Lis ,&nbsp;Maria Merino ,&nbsp;Denise Young ,&nbsp;G. Thomas Brown ,&nbsp;Kimberly M. Greenfield ,&nbsp;John D. McGeeney ,&nbsp;Sally Elsamanoudi ,&nbsp;Shyh-Han Tan ,&nbsp;Cara Schafer ,&nbsp;Jiji Jiang ,&nbsp;Gyorgy Petrovics ,&nbsp;Albert Dobi ,&nbsp;Francisco J. Rentas ,&nbsp;Peter A. Pinto ,&nbsp;Gregory T. Chesnut ,&nbsp;Peter Choyke ,&nbsp;Baris Turkbey ,&nbsp;Joel T. Moncur","doi":"10.1016/j.jpi.2024.100381","DOIUrl":"10.1016/j.jpi.2024.100381","url":null,"abstract":"<div><p>The Gleason score is an important predictor of prognosis in prostate cancer. However, its subjective nature can result in over- or under-grading. Our objective was to train an artificial intelligence (AI)-based algorithm to grade prostate cancer in specimens from patients who underwent radical prostatectomy (RP) and to assess the correlation of AI-estimated proportions of different Gleason patterns with biochemical recurrence-free survival (RFS), metastasis-free survival (MFS), and overall survival (OS). Training and validation of algorithms for cancer detection and grading were completed with three large datasets containing a total of 580 whole-mount prostate slides from 191 RP patients at two centers and 6218 annotated needle biopsy slides from the publicly available Prostate Cancer Grading Assessment dataset. A cancer detection model was trained using MobileNetV3 on 0.5 mm × 0.5 mm cancer areas (tiles) captured at 10× magnification. For cancer grading, a Gleason pattern detector was trained on tiles using a ResNet50 convolutional neural network and a selective CutMix training strategy involving a mixture of real and artificial examples. This strategy resulted in improved model generalizability in the test set compared with three different control experiments when evaluated on both needle biopsy slides and whole-mount prostate slides from different centers. In an additional test cohort of RP patients who were clinically followed over 30 years, quantitative Gleason pattern AI estimates achieved concordance indexes of 0.69, 0.72, and 0.64 for predicting RFS, MFS, and OS times, outperforming the control experiments and International Society of Urological Pathology system (ISUP) grading by pathologists. Finally, unsupervised clustering of test RP patient specimens into low-, medium-, and high-risk groups based on AI-estimated proportions of each Gleason pattern resulted in significantly improved RFS and MFS stratification compared with ISUP grading. In summary, deep learning-based quantitative Gleason scoring using a selective CutMix training strategy may improve prognostication after prostate cancer surgery.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100381"},"PeriodicalIF":0.0,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000208/pdfft?md5=3e256673a8f52212fb05001cc4e50f5b&pid=1-s2.0-S2153353924000208-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation and three years of clinical experience in using an artificial intelligence algorithm as a second read system for prostate cancer diagnosis—real-world experience","authors":"Juan Carlos Santa-Rosario,&nbsp;Erik A. Gustafson,&nbsp;Dario E. Sanabria Bellassai,&nbsp;Phillip E. Gustafson,&nbsp;Mariano de Socarraz","doi":"10.1016/j.jpi.2024.100378","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100378","url":null,"abstract":"<div><h3>Background</h3><p>Prostate cancer ranks as the most frequently diagnosed cancer in men in the USA, with significant mortality rates. Early detection is pivotal for optimal patient outcomes, providing increased treatment options and potentially less invasive interventions. There remain significant challenges in prostate cancer histopathology, including the potential for missed diagnoses due to pathologist variability and subjective interpretations.</p></div><div><h3>Methods</h3><p>To address these challenges, this study investigates the ability of artificial intelligence (AI) to enhance diagnostic accuracy. The Galen™ Prostate AI algorithm was validated on a cohort of Puerto Rican men to demonstrate its efficacy in cancer detection and Gleason grading. Subsequently, the AI algorithm was integrated into routine clinical practice during a 3-year period at a CLIA certified precision pathology laboratory.</p></div><div><h3>Results</h3><p>The Galen™ Prostate AI algorithm showed a 96.7% (95% CI 95.6–97.8) specificity and a 96.6% (95% CI 93.3–98.8) sensitivity for prostate cancer detection and 82.1% specificity (95% CI 73.9–88.5) and 81.1% sensitivity (95% CI 73.7–87.2) for distinction of Gleason Grade Group 1 from Grade Group 2+. The subsequent AI integration into routine clinical use examined prostate cancer diagnoses on &gt;122,000 slides and 9200 cases over 3 years and had an overall AI Impact ™ factor of 1.8%.</p></div><div><h3>Conclusions</h3><p>The potential of AI to be a powerful, reliable, and effective diagnostic tool for pathologists is highlighted, while the AI Impact™ in a real-world setting demonstrates the ability of AI to standardize prostate cancer diagnosis at a high level of performance across pathologists.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100378"},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000178/pdfft?md5=9c3ac8cee3a0de7c2dbd11239bf2bccb&pid=1-s2.0-S2153353924000178-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141164206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathologists light level preferences using the microscope—study to guide digital pathology display use","authors":"Charlotte Jennings ,&nbsp;Darren Treanor ,&nbsp;David Brettle","doi":"10.1016/j.jpi.2024.100379","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100379","url":null,"abstract":"<div><h3>Background</h3><p>Currently, there is a paucity of guidelines relating to displays used for digital pathology making procurement decisions, and optimal display configuration, challenging.</p><p>Experience suggests pathologists have personal preferences for brightness when using a conventional microscope which we hypothesized could be used as a predictor for display setup.</p></div><div><h3>Methods</h3><p>We conducted an online survey across six NHS hospitals, totalling 108 practicing pathologists, to capture brightness adjustment habits on both microscopes and displays.</p><p>A convenience subsample of respondents was then invited to take part in a practical task to determine microscope brightness and display luminance preferences in the normal working environment. A novel adaptation for a lightmeter was developed to directly measure the light output from the microscope eyepiece.</p></div><div><h3>Results</h3><p>The survey (response rate 59% <em>n</em>=64) indicates 81% of respondents adjust the brightness on their microscope. In comparison, only 11% report adjusting their digital display. Display adjustments were more likely to be for visual comfort and ambient light compensation rather than for tissue factors, common for microscope adjustments. Part of this discrepancy relates to lack of knowledge of how to adjust displays and lack of guidance on whether this is safe; But, 66% felt that the ability to adjust the light on the display was important.</p><p>Twenty consultants took part in the practical brightness assessment. Light preferences on the microscope showed no correlation with display preferences, except where a pathologist has a markedly brighter microscope light preference. All of the preferences in this cohort were for a display luminance of &lt;500 cd/m², with 90% preferring 350 cd/m² or less. There was no correlation between these preferences and the ambient lighting in the room.</p></div><div><h3>Conclusions</h3><p>We conclude that microscope preferences can only be used to predict display luminance requirements where the microscope is being used at very high brightness levels. A display capable of a brightness of 500 cd/m² should be suitable for almost all pathologists with 300 cd/m² suitable for the majority. Although display luminance is not frequently changed by users, the ability to do so was felt to be important by the majority of respondents.</p><p>Further work needs to be undertaken to establish the relationship between diagnostic performance, luminance preferences, and ambient lighting levels.</p></div>","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100379"},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S215335392400018X/pdfft?md5=0134b221667c45b419ce808d463b9b22&pid=1-s2.0-S215335392400018X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141164205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AI-algorithm training and validation for identification of endometrial CD138+ cells in infertility-associated conditions; polycystic ovary syndrome (PCOS) and recurrent implantation failure (RIF)","authors":"Seungbaek Lee ,&nbsp;Riikka K. Arffman ,&nbsp;Elina K. Komsi ,&nbsp;Outi Lindgren ,&nbsp;Janette A. Kemppainen ,&nbsp;Hanna Metsola ,&nbsp;Henna-Riikka Rossi ,&nbsp;Anne Ahtikoski ,&nbsp;Keiu Kask ,&nbsp;Merli Saare ,&nbsp;Andres Salumets ,&nbsp;Terhi T. Piltonen","doi":"10.1016/j.jpi.2024.100380","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100380","url":null,"abstract":"<div><h3>Background</h3><p>Endometrial CD138+ plasma cells serve as a diagnostic biomarker for endometrial inflammation, and their elevated occurrence correlates positively with adverse pregnancy outcomes. Infertility-related conditions like polycystic ovary syndrome (PCOS) and recurrent implantation failure (RIF) are closely associated with systemic and local chronic inflammatory status, wherein endometrial CD138+ plasma cell accumulation could also contribute to endometrial pathology. Current methods for quantifying CD138+ cells typically involve laborious and time-consuming microscopic assessments of only a few random areas from a slide. These methods have limitations in accurately representing the entire slide and are susceptible to significant biases arising from intra- and interobserver variations. Implementing artificial intelligence (AI) for CD138+ cell identification could enhance the accuracy, reproducibility, and reliability of analysis.</p></div><div><h3>Methods</h3><p>Here, an AI algorithm was developed to identify CD138+ plasma cells within endometrial tissue. The AI model comprised two layers of convolutional neural networks (CNNs). CNN1 was trained to segment epithelium and stroma across 28,363 mm² (2.56 mm² of epithelium and 24.87 mm² of stroma), while CNN2 was trained to distinguish stromal cells based on CD138 staining, encompassing 7345 cells in the object layers (6942 CD138− cells and 403 CD138+ cells). The training and performance of the AI model were validated by three experienced pathologists. We collected 193 endometrial tissues from healthy controls (<em>n</em> = 73), women with PCOS (<em>n</em> = 91), and RIF patients (<em>n</em> = 29) and compared the CD138+ cell percentages based on cycle phases, ovulation status, and endometrial receptivity utilizing the AI model.</p></div><div><h3>Results</h3><p>The AI algorithm consistently and reliably distinguished CD138− and CD138+ cells, with total error rates of 6.32% and 3.23%, respectively. During the training validation, there was a complete agreement between the decisions made by the pathologists and the AI algorithm, while the performance validation demonstrated excellent accuracy between the AI and human evaluation methods (intraclass correlation; 0.76, 95% confidence intervals; 0.36–0.93, <em>p</em> = 0.002) and a positive correlation (Spearman's rank correlation coefficient: 0.79, <em>p</em> &lt; 0.01). In the AI analysis, the AI model revealed higher CD138+ cell percentages in the proliferative phase (PE) endometrium compared to the secretory phase or anovulatory PCOS endometrium, irrespective of PCOS diagnosis. Interestingly, CD138+ percentages differed according to PCOS phenotype in the PE (<em>p</em> = 0.03). On the other hand, the receptivity status had no impact on the cell percentages in RIF samples.</p></div><div><h3>Conclusion</h3><p>Our findings emphasize the potential and accuracy of the AI algorithm in detecting endometrial ","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100380"},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000191/pdfft?md5=e87bcb34b2122d5de74031fb378126b2&pid=1-s2.0-S2153353924000191-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141084391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding the financial aspects of digital pathology: A dynamic customizable return on investment calculator for informed decision-making","authors":"Orly Ardon ,&nbsp;Sylvia L. Asa ,&nbsp;Mark C. Lloyd ,&nbsp;Giovanni Lujan ,&nbsp;Anil Parwani ,&nbsp;Juan C. Santa-Rosario ,&nbsp;Bryan Van Meter ,&nbsp;Jennifer Samboy ,&nbsp;Danielle Pirain ,&nbsp;Scott Blakely ,&nbsp;Matthew G. Hanna","doi":"10.1016/j.jpi.2024.100376","DOIUrl":"https://doi.org/10.1016/j.jpi.2024.100376","url":null,"abstract":"<div><h3>Background</h3><p>The adoption of digital pathology has transformed the field of pathology, however, the economic impact and cost analysis of implementing digital pathology solutions remain a critical consideration for institutions to justify. Digital pathology implementation requires a thorough evaluation of associated costs and should identify and optimize resource allocation to facilitate informed decision-making. A dynamic cost calculator to estimate the financial implications of deploying digital pathology systems was needed to estimate the financial effects on transitioning to a digital workflow.</p></div><div><h3>Methods</h3><p>A systematic approach was used to comprehensively assess the various components involved in implementing and maintaining a digital pathology system. This consisted of: (1) identification of key cost categories associated with digital pathology implementation; (2) data collection and analysis of cost estimation; (3) cost categorization and quantification of direct and indirect costs associated with different use cases, allowing customization of each factor based on specific intended uses and market rates, industry standards, and regional variations; (4) opportunities for savings realized by digitization of glass slides and (5) integration of the cost calculator into a unified framework for a holistic view of the financial implications associated with digital pathology implementation. The online tool enables the user to test various scenarios specific to their institution and provides adjustable parameters to assure organization specific relatability.</p></div><div><h3>Results</h3><p>The Digital Pathology Association has developed a web-based calculator as a companion tool to provide an exhaustive list of the necessary concepts needed when assessing the financial implications of transitioning to a digital pathology system. The dynamic return on investment (ROI) calculator successfully integrated relevant cost and cost-saving components associated with digital pathology implementation and maintenance. Considerations include factors such as digital pathology infrastructure, clinical operations, staffing, hardware and software, information technology, archive and retrieval, medical–legal, and potential reimbursements. The ROI calculator developed for digital pathology workflows offers a comprehensive, customizable tool for institutions to assess their anticipated upfront and ongoing annual costs as they start or expand their digital pathology journey. It also offers cost-savings analysis based on specific user case volume, institutional geographic considerations, and actual costs. In addition, the calculator also serves as a tool to estimate number of required whole slide scanners, scanner throughput, and data storage (TB). This tool is intended to estimate the potential costs and cost savings resulting from the transition to digital pathology for business plan justifications and return on investment calculation","PeriodicalId":37769,"journal":{"name":"Journal of Pathology Informatics","volume":"15 ","pages":"Article 100376"},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2153353924000154/pdfft?md5=06d1c9d9fe955e29390f2e8c6402cf66&pid=1-s2.0-S2153353924000154-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140825437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}